Cargando…
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756109/ https://www.ncbi.nlm.nih.gov/pubmed/33362563 http://dx.doi.org/10.3389/fphar.2020.609274 |
_version_ | 1783626469579161600 |
---|---|
author | Viegas, Claudio Fraga, Carlos A. Manssour Sousa, Maria Emilia Tarozzi, Andrea |
author_facet | Viegas, Claudio Fraga, Carlos A. Manssour Sousa, Maria Emilia Tarozzi, Andrea |
author_sort | Viegas, Claudio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7756109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77561092020-12-24 Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? Viegas, Claudio Fraga, Carlos A. Manssour Sousa, Maria Emilia Tarozzi, Andrea Front Pharmacol Pharmacology Frontiers Media S.A. 2020-12-09 /pmc/articles/PMC7756109/ /pubmed/33362563 http://dx.doi.org/10.3389/fphar.2020.609274 Text en Copyright © 2020 Viegas, Fraga, Sousa and Tarozzi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Viegas, Claudio Fraga, Carlos A. Manssour Sousa, Maria Emilia Tarozzi, Andrea Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title | Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_full | Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_fullStr | Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_full_unstemmed | Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_short | Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_sort | editorial: oxidative stress: how has it been considered in the design of new drug candidates for neurodegenerative diseases? |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756109/ https://www.ncbi.nlm.nih.gov/pubmed/33362563 http://dx.doi.org/10.3389/fphar.2020.609274 |
work_keys_str_mv | AT viegasclaudio editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT fragacarlosamanssour editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT sousamariaemilia editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT tarozziandrea editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases |